GetPortalImpactFactorByIdResp(projectId=1, id=15bc15035, cover=https://img.medsci.cn/images/journal/cover/2021/dyp_202109271316439260.jpg, fullname=Translational Andrology and Urology, abbr=TRANSL ANDROL UROL, pyear=暂无数据, frequence=null, articleNumbers=1935, citedSelf2015=null, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均3.25月, reviewFee=null, pageFee=1390.0, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=2223-4683, greenSci=https://www.greensci.net/search?kw=2223-4683, scijournal=https://www.scijournal.org/impact-factor-of-TRANSL-ANDROL-UROL.shtml, medsciHotlightString=null, medsciHotlightRealtime=4.465, medsciHotlight=8.567, medsciHotlight5year=2.5396, citescore=4.1, hIndex=27, impactFactor=2.0, orgnization=AME Publishing Company, orgnizationUrl=https://www.amegroups.com/, country=China, countryCn=中国大陆, isOa=1, isOaString=是, sciScie=Science Citation Index Expanded (SCIE)；PubMed；PubMed Central (PMC)；Scopus；Google Scholar；Medscape；MDlinx, bigclassCas=医学 3区, smallclassCas=医学 4 区, website=https://tau.amegroups.com/, websiteHits=1529, guideForAuthor=https://tau.amegroups.com/pages/view/guidelines-for-authors, guideForAuthorHits=474, submitWebsite=https://auth.amegroups.cn/sign-in?service=https%3A%2F%2Ftau.amegroups.com%2Flogin%3Fsource%3D%252Fauthor%252Fsubmit&lang=en-US, submitWebsiteHits=950, content=<h1 class="page-title" style="color: #178a84;">Translational Andrology and Urology</h1> <div class="description" style="color: #333333;"> <p align="left"><strong><span lang="EN-US">Aims and Scope</span></strong></p> <p><em><span lang="EN-US">Translational Andrology and Urology</span></em><span lang="EN-US"> (Print ISSN 2223-4683; Online ISSN 2223-4691; Transl Androl Urol; TAU) is an open access, peer-reviewed, monthly journal (quarterly published from Mar. 2012 to Dec. 2014; bimonthly published from Jan. 2015 to Dec. 2020). TAU delivers up-to-date findings and provides current and practical information on basic and clinical research of andrology and urology. It publishes articles that cover various aspects in diseases of male and female urinary tract including kidneys, ureters, bladder and urethra and the male reproductive organs like penis, testes, scrotum, prostate etc. Contributions pertinent to urology and andrology are also included from related fields such as public health, basic sciences, education, sociology, and nursing.<br /><br />TAU is indexed in PubMed/PubMed Central, Scopus and Science Citation Index Expanded (SCIE) and the SCIE impact factor 2020 for TAU is 3.15. TAU is endorsed by the Genitourinary Medical Association of China International Exchange and Promotive Association for Medical and Health Care (GUA-CPAM).</span></p> <p><span lang="EN-US">The entire submission and review process are managed through OJS system, an electronic system, which provides an efficient way and ensures a rapid turnaround of papers submitted for publication. Articles will be published both in print and online. See more at </span><span lang="EN-US"><a style="color: #178a84;" href="https://www.amepc.org/public/system/tau/tau-instruction-for-authors.pdf">Information for Authors</a></span><span lang="EN-US">.</span><span lang="EN-US"><br /></span></p> <p><strong><span lang="EN-US">Information for Authors</span></strong></p> <p><span lang="EN-US">TAU follows the ICMJE recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journal and the Committee on Publication Ethics (COPE)'s guidelines.</span></p> <p><span lang="EN-US">Manuscripts submitted must be the original work of the author(s) and must not be published previously or under consideration for publication elsewhere.</span></p> <p><strong><span lang="EN-US">Manuscripts Turnaround Time</span></strong></p> <p> </p> <ul> <li>In-house review: 1-3 weeks</li> <li>External peer review: 1-3 months</li> <li>Publication Ahead of Print: within 1 month after being accepted</li> <li>Formal publication: within 1-3 months after being accepted. Original Articles are listed as priority.</li> </ul> </div>, totalCites=3870, brief=TRANSL ANDROL UROL杂志暂不明确行业，暂不明确子行业的级别不明杂志, articleType=本刊接收类型不明, medsciHeat=<span style="color: #990000;">暗红</span>, medsciComment=TRANSL ANDROL UROL杂志级别还可以，但是相对来说，比较冷门，关注人数偏少，有些可能是国内不太熟悉，但该杂志在国际仍然有相当知晓度的。因为缺少中国人投稿，稿源可能未必丰富，发表有可能有很大的机会哦。, medsciExplanation=MedSci期刊指数是根据中国科研工作者（含医学临床，基础，生物，化学等学科）对SCI杂志的认知度，熟悉程度，以及投稿的量等众多指标综合评定而成。当然，具体的，您还可以结合“<a href='//m.capotfarm.com/sci/submit.do?id=15bc15035'>投稿经验系统</a>”，进行综合判断，这更是大家的实战经验，值得分享和参考。<br> 注意，上述MedSci期刊指数采用MedSci专利技术，由计算机系统自动计算，并给出建议，存在不准确的可能，仅供您投稿选择杂志时参考。, tags=[ImpactFactorTagDto(id=70175, tagName=泌尿系统肿瘤, createdHits=1)], citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2020, citescore=2.8), GetImpactFactorCiteScoreListResponse(year=2023, citescore=4.1)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=4.254), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=8.444), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=8.182), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=5.521), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=4.465)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Urology , rank=43/100), GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Reproductive Medicine , rank=34/63)], totalJcrAreaList=[], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2223-4683[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=Translational Andrology and Urology[ta], article_number=131, article_number_cn=94, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)